• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA 20GA 1.25IN HF Y; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA 20GA 1.25IN HF Y; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383537
Device Problem Packaging Problem (3007)
Patient Problems No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/28/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that nexiva 20ga 1.25in hf y package was damaged.This occurred on 11 occasions.The following information was provided by the initial reporter: this is a report about damaged packages.According to the customer's report, the package component (plastic tray) was damaged (deformed) in 11 of 20 products.(additional information on 02/03/2021).The periphery of the package tray was partly deformed sharply (upper part) or cut diagonally (lower part) and the customer is questioning whether sterilization of the package has been guaranteed.
 
Event Description
It was reported that nexiva 20ga 1.25in hf y package was damaged.This occurred on 11 occasions.The following information was provided by the initial reporter: this is a report about damaged packages.According to the customer's report, the package component (plastic tray) was damaged (deformed) in 11 of 20 products.(additional information on 02/03/2021) the periphery of the package tray was partly deformed sharply (upper part) or cut diagonally (lower part) and the customer is questioning whether sterilization of the package has been guaranteed.
 
Manufacturer Narrative
The following fields were updated due to additional information: d.10.Device available for eval?: yes.D.10.Returned to manufacturer on: 2/16/2021.H.6.Investigation: our quality engineer inspected the samples and photographs submitted for evaluation.Bd received eleven unopened units and seven photos.During the visual examination of the units and photos, it was observed that excess material and sharp edges were present confirming the reported defect.Misalignment or incorrect setup during the cutting process may result in excess material like that observed in the returned units resulting in sharp edges; therefore, the most probable root cause is manufacturing.The seal width was measured to determine if a sufficient seal was made.All eleven seals were found to be within specification indicating that the sterility was not affected by the defect.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXIVA 20GA 1.25IN HF Y
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key11370289
MDR Text Key233568574
Report Number1710034-2021-00140
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903835379
UDI-Public00382903835379
Combination Product (y/n)N
PMA/PMN Number
K183399
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 03/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date05/31/2023
Device Catalogue Number383537
Device Lot Number0168884
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/16/2021
Initial Date Manufacturer Received 01/28/2021
Initial Date FDA Received02/24/2021
Supplement Dates Manufacturer Received03/29/2021
Supplement Dates FDA Received04/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-